img

Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Bruton's Tyrosine Kinase Inhibitors (BTKi), Bruton's TKI or BTKI, Ibrutinib, has shown great promise for B cell cancers with the unfortunate side effect of increased incidence of atrial fibrillation. Bruton's tyrosine kinase (BTK) inhibitors work by binding to the BTK protein. BTK inhibitors block this protein's activity by the BCR-induced BTK activation and its downstream signalling. BTK inhibitors block the activity that leads to growth of the B-cells and this causes cell death of the malignant B-cells.
Global Bruton's Tyrosine Kinase (BTKi) Inhibitors market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Chronic Lymphocytic Leukemia and Follicular Lymphoma are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Bruton's Tyrosine Kinase (BTKi) Inhibitors industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Bruton's Tyrosine Kinase (BTKi) Inhibitors key manufacturers include Johnson & Johnson, AbbVie, AstraZeneca, BeiGene, InnoCare and Ono Pharmaceutical, etc. Johnson & Johnson, AbbVie, AstraZeneca are top 3 players and held % sales share in total in 2022.
Bruton's Tyrosine Kinase (BTKi) Inhibitors can be divided into 1st Line Treatment, 2nd Line Treatment and 3rd Line and Above Treatment,, etc. 1st Line Treatment is the mainstream product in the market, accounting for % sales share globally in 2022.
Bruton's Tyrosine Kinase (BTKi) Inhibitors is widely used in various fields, such as Chronic Lymphocytic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma and Marginal Zone Lymphoma, etc. Chronic Lymphocytic Leukemia provides greatest supports to the Bruton's Tyrosine Kinase (BTKi) Inhibitors industry development. In 2022, global % sales of Bruton's Tyrosine Kinase (BTKi) Inhibitors went into Chronic Lymphocytic Leukemia filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bruton's Tyrosine Kinase (BTKi) Inhibitors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Johnson & Johnson
AbbVie
AstraZeneca
BeiGene
InnoCare
Ono Pharmaceutical
Segment by Type
1st Line Treatment
2nd Line Treatment
3rd Line and Above Treatment

Segment by Application


Chronic Lymphocytic Leukemia
Follicular Lymphoma
Mantle Cell Lymphoma
Marginal Zone Lymphoma
Small Lymphocytic Lymphoma
Waldenstrom Macroglobulinemia
B Cell Malignancies
Chronic Graft-Versus-Host Disease
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bruton's Tyrosine Kinase (BTKi) Inhibitors market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Bruton's Tyrosine Kinase (BTKi) Inhibitors, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Bruton's Tyrosine Kinase (BTKi) Inhibitors industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Bruton's Tyrosine Kinase (BTKi) Inhibitors in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Bruton's Tyrosine Kinase (BTKi) Inhibitors introduction, etc. Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Bruton's Tyrosine Kinase (BTKi) Inhibitors market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Overview
1.1 Bruton's Tyrosine Kinase (BTKi) Inhibitors Product Overview
1.2 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Segment by Type
1.2.1 1st Line Treatment
1.2.2 2nd Line Treatment
1.2.3 3rd Line and Above Treatment
1.3 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size by Type
1.3.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size Overview by Type (2018-2029)
1.3.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Historic Market Size Review by Type (2018-2024)
1.3.3 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Breakdown by Type (2018-2024)
1.4.2 Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Breakdown by Type (2018-2024)
2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Competition by Company
2.1 Global Top Players by Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (2018-2024)
2.2 Global Top Players by Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue (2018-2024)
2.3 Global Top Players by Bruton's Tyrosine Kinase (BTKi) Inhibitors Price (2018-2024)
2.4 Global Top Manufacturers Bruton's Tyrosine Kinase (BTKi) Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Competitive Situation and Trends
2.5.1 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bruton's Tyrosine Kinase (BTKi) Inhibitors as of 2022)
2.7 Date of Key Manufacturers Enter into Bruton's Tyrosine Kinase (BTKi) Inhibitors Market
2.8 Key Manufacturers Bruton's Tyrosine Kinase (BTKi) Inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Bruton's Tyrosine Kinase (BTKi) Inhibitors Status and Outlook by Region
3.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Historic Market Size by Region
3.2.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Volume by Region (2018-2024)
3.2.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Value by Region (2018-2024)
3.2.3 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Forecasted Market Size by Region
3.3.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Volume by Region (2024-2029)
3.3.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Value by Region (2024-2029)
3.3.3 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors by Application
4.1 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Segment by Application
4.1.1 Chronic Lymphocytic Leukemia
4.1.2 Follicular Lymphoma
4.1.3 Mantle Cell Lymphoma
4.1.4 Marginal Zone Lymphoma
4.1.5 Small Lymphocytic Lymphoma
4.1.6 Waldenstrom Macroglobulinemia
4.1.7 B Cell Malignancies
4.1.8 Chronic Graft-Versus-Host Disease
4.1.9 Others
4.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size by Application
4.2.1 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size Overview by Application (2018-2029)
4.2.2 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Historic Market Size Review by Application (2018-2024)
4.2.3 Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Breakdown by Application (2018-2024)
4.3.2 Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Breakdown by Application (2018-2024)
5 North America Bruton's Tyrosine Kinase (BTKi) Inhibitors by Country
5.1 North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Historic Market Size by Country
5.1.1 North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Volume by Country (2018-2024)
5.1.3 North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Value by Country (2018-2024)
5.2 North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Forecasted Market Size by Country
5.2.1 North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Volume by Country (2024-2029)
5.2.2 North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Value by Country (2024-2029)
6 Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors by Country
6.1 Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Historic Market Size by Country
6.1.1 Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Volume by Country (2018-2024)
6.1.3 Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Value by Country (2018-2024)
6.2 Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Forecasted Market Size by Country
6.2.1 Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Volume by Country (2024-2029)
6.2.2 Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Value by Country (2024-2029)
7 Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors by Region
7.1 Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Historic Market Size by Region
7.1.1 Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Forecasted Market Size by Region
7.2.1 Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Value by Region (2024-2029)
8 Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors by Country
8.1 Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Historic Market Size by Country
8.1.1 Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Volume by Country (2018-2024)
8.1.3 Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Value by Country (2018-2024)
8.2 Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Forecasted Market Size by Country
8.2.1 Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Volume by Country (2024-2029)
8.2.2 Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Value by Country (2024-2029)
9 Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors by Country
9.1 Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Historic Market Size by Country
9.1.1 Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Forecasted Market Size by Country
9.2.1 Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Johnson & Johnson Bruton's Tyrosine Kinase (BTKi) Inhibitors Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 AbbVie
10.2.1 AbbVie Company Information
10.2.2 AbbVie Introduction and Business Overview
10.2.3 AbbVie Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AbbVie Bruton's Tyrosine Kinase (BTKi) Inhibitors Products Offered
10.2.5 AbbVie Recent Development
10.3 AstraZeneca
10.3.1 AstraZeneca Company Information
10.3.2 AstraZeneca Introduction and Business Overview
10.3.3 AstraZeneca Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.3.4 AstraZeneca Bruton's Tyrosine Kinase (BTKi) Inhibitors Products Offered
10.3.5 AstraZeneca Recent Development
10.4 BeiGene
10.4.1 BeiGene Company Information
10.4.2 BeiGene Introduction and Business Overview
10.4.3 BeiGene Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.4.4 BeiGene Bruton's Tyrosine Kinase (BTKi) Inhibitors Products Offered
10.4.5 BeiGene Recent Development
10.5 InnoCare
10.5.1 InnoCare Company Information
10.5.2 InnoCare Introduction and Business Overview
10.5.3 InnoCare Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.5.4 InnoCare Bruton's Tyrosine Kinase (BTKi) Inhibitors Products Offered
10.5.5 InnoCare Recent Development
10.6 Ono Pharmaceutical
10.6.1 Ono Pharmaceutical Company Information
10.6.2 Ono Pharmaceutical Introduction and Business Overview
10.6.3 Ono Pharmaceutical Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Ono Pharmaceutical Bruton's Tyrosine Kinase (BTKi) Inhibitors Products Offered
10.6.5 Ono Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bruton's Tyrosine Kinase (BTKi) Inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bruton's Tyrosine Kinase (BTKi) Inhibitors Industrial Chain Analysis
11.4 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Dynamics
11.4.1 Bruton's Tyrosine Kinase (BTKi) Inhibitors Industry Trends
11.4.2 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Drivers
11.4.3 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Challenges
11.4.4 Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bruton's Tyrosine Kinase (BTKi) Inhibitors Distributors
12.3 Bruton's Tyrosine Kinase (BTKi) Inhibitors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 1st Line Treatment
Table 2. Major Company of 2nd Line Treatment
Table 3. Major Company of 3rd Line and Above Treatment
Table 4. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Type (2018-2024) & (K Units)
Table 6. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Type (2018-2024) & (US& Million)
Table 8. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Share in Value by Type (2018-2024)
Table 9. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Type (2024-2029) & (K Units)
Table 11. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Type (2024-2029)
Table 14. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Price by Type (2024-2029) & (US$/Unit)
Table 15. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Type (2018-2024) & (K Units)
Table 16. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units) by Type (2018-2024)
Table 18. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units) by Type (2018-2024)
Table 22. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Company (2018-2024) & (K Units)
Table 26. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Share by Company (2018-2024)
Table 27. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue Share by Company (2018-2024)
Table 29. Global Market Bruton's Tyrosine Kinase (BTKi) Inhibitors Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bruton's Tyrosine Kinase (BTKi) Inhibitors as of 2022)
Table 33. Date of Key Manufacturers Enter into Bruton's Tyrosine Kinase (BTKi) Inhibitors Market
Table 34. Key Manufacturers Bruton's Tyrosine Kinase (BTKi) Inhibitors Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Region (2018-2024) & (K Units)
Table 38. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 41. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Region (2024-2029) & (K Units)
Table 43. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Region (2024-2029)
Table 46. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2018-2024) & (K Units)
Table 49. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Application (2018-2024)
Table 52. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2024-2029) & (K Units)
Table 54. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Application (2024-2029)
Table 57. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Price by Application (2024-2029) & (US$/Unit)
Table 58. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2018-2024) (K Units)
Table 59. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2018-2024) (K Units)
Table 61. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2018-2024) (K Units)
Table 65. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2018-2024) & (K Units)
Table 69. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 72. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2024-2029) & (K Units)
Table 73. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2018-2024) & (K Units)
Table 77. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2024-2029) & (K Units)
Table 81. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 108. Johnson & Johnson Company Information
Table 109. Johnson & Johnson Introduction and Business Overview
Table 110. Johnson & Johnson Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Johnson & Johnson Bruton's Tyrosine Kinase (BTKi) Inhibitors Product
Table 112. Johnson & Johnson Recent Development
Table 113. AbbVie Company Information
Table 114. AbbVie Introduction and Business Overview
Table 115. AbbVie Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. AbbVie Bruton's Tyrosine Kinase (BTKi) Inhibitors Product
Table 117. AbbVie Recent Development
Table 118. AstraZeneca Company Information
Table 119. AstraZeneca Introduction and Business Overview
Table 120. AstraZeneca Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. AstraZeneca Bruton's Tyrosine Kinase (BTKi) Inhibitors Product
Table 122. AstraZeneca Recent Development
Table 123. BeiGene Company Information
Table 124. BeiGene Introduction and Business Overview
Table 125. BeiGene Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. BeiGene Bruton's Tyrosine Kinase (BTKi) Inhibitors Product
Table 127. BeiGene Recent Development
Table 128. InnoCare Company Information
Table 129. InnoCare Introduction and Business Overview
Table 130. InnoCare Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. InnoCare Bruton's Tyrosine Kinase (BTKi) Inhibitors Product
Table 132. InnoCare Recent Development
Table 133. Ono Pharmaceutical Company Information
Table 134. Ono Pharmaceutical Introduction and Business Overview
Table 135. Ono Pharmaceutical Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Ono Pharmaceutical Bruton's Tyrosine Kinase (BTKi) Inhibitors Product
Table 137. Ono Pharmaceutical Recent Development
Table 138. Key Raw Materials Lists
Table 139. Raw Materials Key Suppliers Lists
Table 140. Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Trends
Table 141. Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Drivers
Table 142. Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Challenges
Table 143. Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Restraints
Table 144. Bruton's Tyrosine Kinase (BTKi) Inhibitors Distributors List
Table 145. Bruton's Tyrosine Kinase (BTKi) Inhibitors Downstream Customers
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Bruton's Tyrosine Kinase (BTKi) Inhibitors Product Picture
Figure 2. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of 1st Line Treatment
Figure 6. Global 1st Line Treatment Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of 2nd Line Treatment
Figure 8. Global 2nd Line Treatment Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of 3rd Line and Above Treatment
Figure 10. Global 3rd Line and Above Treatment Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Type in 2022 & 2029
Figure 13. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 14. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Type in 2022
Figure 15. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 16. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Type in 2022
Figure 19. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Bruton's Tyrosine Kinase (BTKi) Inhibitors Revenue in 2022
Figure 25. Bruton's Tyrosine Kinase (BTKi) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Chronic Lymphocytic Leukemia
Figure 27. Global Chronic Lymphocytic Leukemia Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Follicular Lymphoma
Figure 29. Global Follicular Lymphoma Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Mantle Cell Lymphoma
Figure 31. Global Mantle Cell Lymphoma Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Marginal Zone Lymphoma
Figure 33. Global Marginal Zone Lymphoma Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Small Lymphocytic Lymphoma
Figure 35. Global Small Lymphocytic Lymphoma Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Product Picture of Waldenstrom Macroglobulinemia
Figure 37. Global Waldenstrom Macroglobulinemia Sales YoY Growth (2018-2029) & (K Units)
Figure 38. Product Picture of B Cell Malignancies
Figure 39. Global B Cell Malignancies Sales YoY Growth (2018-2029) & (K Units)
Figure 40. Product Picture of Chronic Graft-Versus-Host Disease
Figure 41. Global Chronic Graft-Versus-Host Disease Sales YoY Growth (2018-2029) & (K Units)
Figure 42. Product Picture of Others
Figure 43. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 44. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales by Application (2018-2029) & (US$ Million)
Figure 45. Global Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share by Application in 2022 & 2029
Figure 46. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Application in 2022
Figure 47. North America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Application in 2022
Figure 48. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Application in 2022
Figure 49. Europe Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Application in 2022
Figure 50. Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Application in 2022
Figure 51. Asia-Pacific Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Application in 2022
Figure 52. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Volume by Application in 2022
Figure 53. Latin America Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Application in 2022
Figure 54. Middle East and Africa Bruton's Tyrosine Kinase (BTKi) Inhibitors Sales Market Share in Value by Application in 2022
Figure 55. Key Raw Materials Price
Figure 56. Bruton's Tyrosine Kinase (BTKi) Inhibitors Manufacturing Cost Structure
Figure 57. Bruton's Tyrosine Kinase (BTKi) Inhibitors Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries